Indexed in Journament

lung cancer (amsterdam, netherlands)

ISSN 1872-8332· EN

Journal Website Certificate of Indexing
Login or register to claim ownership or editorship of this journal.
43.2 / 100
Journament Score
Below Average
Ranked #925 of 29,297 scored journals (34,016 indexed)
30 Articles
Scores higher than 96.8% of scored journals
050100
The Journament Score is computed from platform statistics — reader engagement, accessibility, publication timeliness, keyword breadth, community impact and content distribution — into a single 0–100 figure, recalculated as new articles and metadata are indexed. Dimensions that cannot be measured for this journal are excluded rather than estimated. It is independent of the paid AI Quality Analysis, which never affects this score or the ranking. Full methodology →

About This Journal

Short Name lung cancer
Abbreviated Name lung cancer
ISSN 1872-8332
URL http://www.elsevier.com/wps/find/journaldescription.cws_home/505953/description#description

Quality Profile

7 of 12 dimensions measured
This journal Average of scored journals
Platform statistics — the free Journament Score AI Quality Analysis — separate paid product, ranks nothing

5 of the 12 dimensions could not be measured for this journal. They are left as gaps in the shape rather than plotted as zero.

Show the numbers
Dimension This journal Corpus average
Engagement 31.1 30.5
Accessibility 20.0 23.1
Timeliness 60.0 3.0
Diversity 33.3 26.4
Innovation 70.0 24.1
Community Impact 10.7 4.5
Content Distribution 74.3 89.3
Content Quality — 55.1
Ethics & Transparency — 40.5
Editorial Standards — 33.0
Publication Regularity — 52.9
Geographic Reach — 30.4

Publications Per Year

Articles (30)

2019
Independent prognostic value of ultra-sensitive quantification of tumor pre-treatment T790M subclones in EGFR mutated non-small cell lung cancer (NSCLC) treated by first/second generation TKI, depends on variant allele frequency (VAF): Results of the French cooperative thoracic intergroup (IFCT) biomarkers France project.
Beau-Faller, Michèle;Pencreach, Erwan;Leduc, Charlotte;Blons, Hélène;Merlio, Jean-Philippe;Bringuier, Pierre-Paul;de Fraipont, Florence;Escande, Fabienne;Lemoine, Antoinette;Ouafik, L'Houcine;Denis, Marc;Hofman, Paul;Lacave, Roger;Melaabi, Samia;Langlais, Alexandra;Missy, Pascale;Morin, Franck;Moro-Sibilot, Denis;Barlesi, Fabrice;Cadranel, Jacques;, ;
Vol. 140 , pp. 19-26
473 views DOI Abstract
2019
Pretreatment prognostic nutritional index as a novel biomarker in non-small cell lung cancer patients treated with immune checkpoint inhibitors.
Shoji, Fumihiro;Takeoka, Hiroaki;Kozuma, Yuka;Toyokawa, Gouji;Yamazaki, Koji;Ichiki, Masao;Takeo, Sadanori;
Vol. 136 , pp. 45-51
447 views DOI Abstract
2019
Establishing a histology-specific biologically effective dose threshold for lung stereotactic ablative radiotherapy (SABR): Is ≥100 Gy<inf>10</inf> enough?
Abel, S.
Vol. 135 , pp. 169-174
430 views DOI
2019
Molecular testing for advanced non-small cell lung cancer in Malaysia: Consensus statement from the College of Pathologists, Academy of Medicine Malaysia, the Malaysian Thoracic Society, and the Malaysian Oncological Society.
Rajadurai, Pathmanathan;Cheah, Phaik Leng;How, Soon Hin;Liam, Chong Kin;Annuar, Muhammad Azrif Ahmad;Omar, Norhayati;Othman, Noriah;Marzuki, Nurhayati Mohd;Pang, Yong Kek;Bustamam, Ros Suzanna Ahmad;Tho, Lye Mun;
Vol. 136 , pp. 65-73
413 views DOI Abstract
2019
Be-TeaM: An Italian real-world observational study on second-line therapy for EGFR-mutated NSCLC patients.
Reale, Maria Lucia;Chiari, Rita;Tiseo, Marcello;Vitiello, Fabiana;Barbieri, Fausto;Cortinovis, Diego;Ceresoli, Giovanni Luca;Finocchiaro, Giovanna;Romano, Gianpiero Diego;Piovano, Pier Luigi;Del Conte, Alessandro;Borra, Gloria;Verderame, Francesco;Scotti, Vieri;Nonnis, Daniela;Galetta, Domenico;Sergi, Concetta;Migliorino, Maria Rita;Tonini, Giuseppe;Cecere, Fabiana;Berardi, Rossana;Pino, Maria Simona;Martelli, Olga;Gelibter, Alain;Carta, Annamaria;Vattemi, Emanuela;Pagano, Maria;Zullo, Alessandro;Ferrari, Silvia;Rossi, Antonio;Novello, Silvia;
Vol. 140 , pp. 71-79
396 views DOI Abstract
2001
Docetaxel as neo-adjuvant therapy for radically treatable stage III non-small cell lung cancer: early results of an international phase III study.
K Mattson,R Abratt,G.Velde Ten,K Krofta,D Tonelli,I Avril;K Mattson;R Abratt;G.Velde Ten;K Krofta;D Tonelli;I Avril;
Vol. 34 , pp. 21-23
388 views DOI
2018
Subclonal evolution of pulmonary adenocarcinomas delineated by spatially distributed somatic mitochondrial mutations.
Kazdal, Daniel;Harms, Alexander;Endris, Volker;Penzel, Roland;Oliveira, Cristiano;Kriegsmann, Mark;Longuespée, Rémi;Winter, Hauke;Schneider, Marc A;Muley, Thomas;Pfarr, Nicole;Weichert, Wilko;Stenzinger, Albrecht;Warth, Arne;
Vol. 126 , pp. 80-88
365 views DOI Abstract
2019
Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trial
Fujimoto, D.
Vol. 134 , pp. 274-278
359 views DOI
2020
Covid-19 and lung cancer: A greater fatality rate?
Rogado, Jacobo;Pangua, Cristina;Serrano-Montero, Gloria;Obispo, Berta;Marino, Almudena Martín;Pérez-Pérez, Mar;López-Alfonso, Ana;Gullón, Pedro;Lara, Miguel Ángel;
Vol. 146 , pp. 19-22
339 views DOI Abstract
2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
Buglione, M.
Vol. 141 , pp. 1-8
335 views DOI
2025
Equalizing prognostic disparities in KRAS-mutated stage III NSCLC patients: addition of durvalumab to combined chemoradiotherapy improves survival.
Eklund, Ella A; Orgard, Mathilda; Wallin, Delice; Sayin, Sama I; Fagman, Henrik; Isaksson, Johan; Raghavan, Sukanya; Akyürek, Levent M; Nyman, Jan; Wiel, Clotilde; Hallqvist, Andreas; Sayin, Volkan I
Vol. 204 , pp. 108573
135 views DOI Abstract
2025
Multimodality treatment in synchronous oligometastatic NSCLC: Analysis of the ETOP CHESS trial.
Guckenberger, Matthias; Opitz, Isabelle; Dellaporta, Tereza; Curioni-Fontecedro, Alessandra; Frauenfelder, Thomas; Ribi, Karin; Cerciello, Ferdinando; Sullivan, Ivana; Hendriks, Lizza; Dorta, Miriam; Callejo, Ana; Aerts, Joachim; Addeo, Alfredo; Dingemans, Anne-Marie C; Pasello, Giulia; Provencio, Mariano; de Marinis, Filippo; Mederos-Alfonso, Nuria; Roschitzki-Voser, Heidi; Ruepp, Barbara; Haberecker, Martina; Kammler, Roswitha; Dafni, Urania; Peters, Solange; Stahel, Rolf
Vol. 204 , pp. 108553
104 views DOI Abstract
2020
Optimizing lung cancer radiation treatment worldwide in COVID-19 outbreak.
Liao, Zhongxing;Rivin Del Campo, Eleonor;Salem, Ahmed;Pang, Qingsong;Liu, Hui;Lopez Guerra, Jose Luis;
Vol. 146 , pp. 230-235
313 views DOI Abstract
2020
Covid-19 and lung cancer: A greater fatality rate?
Rogado, Jacobo;Pangua, Cristina;Serrano-Montero, Gloria;Obispo, Berta;Marino, Almudena Martín;Pérez-Pérez, Mar;López-Alfonso, Ana;Gullón, Pedro;Lara, Miguel Ángel;
Vol. 146 , pp. 19-22
339 views DOI Abstract
2020
Impact of delaying initiation of anaplastic lymphoma kinase inhibitor treatment on survival in patients with advanced non-small-cell lung cancer.
Sheinson, Daniel;Wong, William Bruce;Wu, Ning;Mansfield, Aaron Scott;
Vol. 143 , pp. 86-92
297 views DOI Abstract
2020
Is the English Cancer Patient Experience Survey representative? A comparative analysis with the National Lung Cancer Audit
Nartey, Y.
Vol. 140 , pp. 27-34
215 views DOI
2020
Radiosurgery and fractionated stereotactic radiotherapy in oligometastatic/oligoprogressive non-small cell lung cancer patients: Results of a multi-institutional series of 198 patients treated with “curative” intent
Buglione, M.
Vol. 141 , pp. 1-8
335 views DOI
2020
Final progression-free survival results from the J-ALEX study of alectinib versus crizotinib in ALK-positive non-small-cell lung cancer
Nakagawa, K.
Vol. 139 , pp. 195-199
235 views DOI
2020
Attending community-based lung cancer screening influences smoking behaviour in deprived populations
Balata, H.
Vol. 139 , pp. 41-46
253 views DOI
2019
Characteristics of 252 patients with bronchopulmonary neuroendocrine tumours treated at the Copenhagen NET Centre of Excellence
Grøndahl, V.
Vol. 132 , pp. 141-149
236 views DOI
Journament Score
43.2/100 · Below Average
Ranked #925 of 29,297 scored
(34,016 journals indexed)
Platform Statistics
AI Quality Analysis
Separate paid analysis — does not affect ranking.
Journament

Overall Quality Score

43.2/100

Tier: Below Average

The Journament Overall Quality Score is a comprehensive metric that evaluates academic journals across multiple dimensions including engagement, accessibility, diversity, innovation, and community impact.

This score helps researchers, institutions, and publishers understand the holistic quality and impact of a journal beyond traditional metrics.

Engagement Score

31.1/100

Measures user interactions, views, citations, and community involvement with this journal's content.

Higher engagement scores indicate that the journal's content is actively being read, cited, and discussed within the academic community.

Accessibility Score

20.0/100

Evaluates how easily researchers can access journal content, including open access availability, ISSN registration, and indexing.

This metric considers factors such as paywalls, open access policies, and availability across different academic databases and search engines.

Diversity Score

33.3/100

Assesses geographic and institutional diversity of authors, editorial board composition, and topic breadth.

A diverse journal publishes work from various geographic regions, institutions, and covers a broad range of topics within its field.

Innovation Score

70.0/100

Evaluates research novelty, interdisciplinary work, and emerging topics based on AI analysis of article abstracts.

This score reflects how much the journal publishes cutting-edge research, explores new methodologies, and bridges different academic disciplines.

Community Impact Score

10.7/100

Measures scholarly contribution and real-world applications of published research.

This metric evaluates how the journal's research translates into practical applications, policy changes, and benefits to society beyond academia.

Timeliness Score

60.0/100

Evaluates recent publication activity, publication frequency, and currency of research topics.

Higher scores indicate consistent publishing schedules and timely coverage of current research trends.

Content Distribution

74.3/100

Measures how evenly reader attention spreads across the journal's articles, using the Gini coefficient of article clicks.

Higher scores mean readership is distributed across many articles rather than concentrated on one or two.

Ethics & Transparency Score

Not yet measured

Research Integrity (10% weight)

Assesses COPE standards compliance, ethical considerations in research, transparency in methodologies, and reproducibility practices.

This metric ensures the journal maintains high ethical standards and promotes transparent, trustworthy research.

Content Quality Score

Not yet measured

Academic Rigor (20% weight) + Methodology Quality (12%)

Evaluates research methodology soundness, statistical rigor, theoretical framework strength, appropriateness of research methods, data quality, and clarity & readability.

This comprehensive metric ensures published research meets the highest academic standards.

Editorial Diversity Score

Not yet measured

Author Diversity + Interdisciplinary Value (8%)

Measures geographic diversity of authors, institutional variety, editorial board composition, and cross-disciplinary connections.

Diverse editorial teams bring varied perspectives and reduce bias in academic publishing.

Publication Regularity Score

Not yet measured

Assesses consistency of publication schedule, frequency stability, and predictable output patterns.

Regular publication schedules indicate reliable journal operations and consistent workflow management.

Geographic Reach Score

Not yet measured

Evaluates international author representation, global readership distribution, and cross-border research collaboration.

Wide geographic reach indicates global impact and international recognition of the journal's research.